A
Aptamer Group PLC
LSE:APTA
Aptamer Group PLC
LSE:APTA
Price:
0.85
GBX
Market Closed
Market Cap:
£22.9m
Relative Value
The Relative Value of one APTA stock under the Base Case scenario is hidden GBX. Compared to the current market price of 0.85 GBX, Aptamer Group PLC is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
APTA Relative Value
HIDDEN
Multiples Across Competitors
APTA Competitors Multiples
Aptamer Group PLC Competitors
Aptamer Group PLC Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| UK |
A
|
Aptamer Group PLC
LSE:APTA
|
22.9m GBP | 19.1 | -9.5 | -9.6 | -8.7 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
402B USD | 6.6 | 96.4 | 15.8 | 22 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
202.9B USD | 5.5 | 26.3 | 15 | 15 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
182.9B USD | 6.2 | 21.5 | 13.4 | 16.5 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
124.7B USD | 10.4 | 31.6 | 23.9 | 25 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82.1B USD | 5.7 | 18.2 | 13.7 | 15.6 | |
| AU |
|
CSL Ltd
ASX:CSL
|
68.7B AUD | 3.2 | 34.9 | 11.5 | 14.5 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 | |
| NL |
|
argenx SE
XBRU:ARGX
|
39.2B EUR | 11 | 35.2 | 38.3 | 39.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
